Our Mission

Accelerate the delivery of life-changing medicines by revolutionizing pharmaceutical process development. By fusing rigorous, data-driven experimentation with actionable modeling and data science, we transform complex development hurdles into rapid, data-driven solutions, reducing time-to-market and enhancing process robustness for our clients.

Our Founders

Carla Luciani

Camilo Zapata

Process Design and Development Lead

Data Science and AI Lead

15+ years of experience in pharmaceutical process development

15+ years of experience in data science and AI in Pharma

PhD Chemical Engineering

PhD Chemical Engineering

Our Science

Our founders, has been been pushing the boundaries of what is possible in process development, mathematical modeling and data science for many years and in this new phase of their career their goal is to bring that expertise and scientific curiosity to all our clients. Some examples of the innovative work they have done include:

Unit Operations

• Definition of Design Spaces Using Mechanistic Models and Geometric Projections of Probability Maps, Org. Process Res. Dev. 2015, 19, 8, 1012. https://pubs.acs.org/doi/10.1021/acs.oprd.5b00158

• Liquid phase peptide synthesis via one‐pot nanostar sieving (PEPSTAR). Ang Chemie 2021, 60, 14, 7786-7795. https://onlinelibrary.wiley.com/doi/10.1002/anie.202014445

Enabling Capabilities

• Model Guided Development of a Simple Catalytic Method for the Synthesis of Unsymmetrical Stilbenes by Sequential Heck Reactions of Aryl Bromides with Ethylene. Adv Synthesis and Catalysis 2018, 360, 14. https://doi.org/10.1002/adsc.201800167

• API Continuous Cooling and Antisolvent Crystallization for Kinetic Impurity Rejection in cGMP Manufacturing. Org. Process Res. Dev. 2021, 25, 6, 1284-1351. https://pubs.acs.org/doi/abs/10.1021/acs.oprd.0c00345

Impurity Strategy

• Understanding Aqueous Nitrosation Kinetics of 4-Substituted Piperidines to Risk Assess Pharmaceutical Processes and Products. Org Proc. Res. Dev. 2025, 29, 1703-1714. https://pubs.acs.org/doi/abs/10.1021/acs.oprd.5c00037

• Case Studies in the Development of Drug Substance Control Strategies. Org. Process Res Dev. 2015, 19, 8, 935. https://doi.org/10.1021/acs.oprd.5b00146

Tech Transfer

• Continuous GMP Manufacturing for Grignard Reagent/Zincate Synthesis and Negishi Coupling Reaction. Org. Process Res. Dev. 2024, 28, 5, 1734 https://doi.org/10.1021/acs.oprd.3c00361

• Small-Volume Continuous Manufacturing of Merestinib. Part 2. Technology Transfer and cGMP Manufacturing. Org. Process Res. Dev. 2019, 23, 5, 870. https://pubs.acs.org/doi/10.1021/acs.oprd.8b0044